Home NDC 68180-875 Vyfemla
Product NDC 68180-875
11-digit product format 681800875
Labeler code 68180
Product ID 68180-875_c44722bd-9db7-4ea4-b150-7d514b1bc4f7
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name norethindrone and ethinyl estradiol
Dosage form KIT
Labeler Lupin Pharmaceuticals, Inc.
Application ANDA201886
Marketing category ANDA
Marketing start 2020-11-04
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 68180-875-13 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 68180-875-13 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 68180-875-13 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 68180-875-13 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 68180-875-13 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 68180-875-13 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 68180-875-13 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 68180-875-13 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 68180-875-13 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 68180-875-13 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 68180-875-13 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 68180-875-13 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A201886-001 VYFEMLA ETHINYL ESTRADIOL; NORETHINDRONE 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A201886-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 84e616aacf4f…2026-08-18 06:07:40 2026-07 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A201886-001 VYFEMLA 0.035MG;0.4MG TABLET / ORAL-28 AB 2013-09-26 f41ea6bd6efb…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 43 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Vyfemla
Listing expiration 2026-12-31 Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 238015 Internal RxNorm lookup 748797 Internal RxNorm lookup 749736 Internal RxNorm lookup 1485332 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68180-495-74 Vyfemla 21 in 1 BLISTER PACK TABLET 21 0.4 mg 6 68180-875-73 Vyfemla 1 in 1 POUCH KIT 1 6 68180-875-73 Vyfemla 3 in 1 CARTON KIT 3 6
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68180-875 VYFEMLA ( NORETHINDRONE AND ETHINYL ESTRADIOL ) KIT [LUPIN PHARMACEUTICALS, INC.] 5 Current NDC, Legacy NDC, 3 package rows 20241228_175ce5c4-d332-4c97-a0b8-10821dc813ef.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Vyfemla NORETHINDRONE AND ETHINYL ESTRADIOL Lupin Pharmaceuticals, Inc. 175ce5c4-d332-4c97-a0b8-10821dc813ef 2025-11-19 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 201886 application number: ANDA201886 ndc (product): 68180-875
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 68180-495-74 68180049574 21 in 1 BLISTER PACK Historical 68180-875-13 68180087513 3 POUCH in 1 CARTON (68180-875-13) > 1 BLISTER PACK in 1 POUCH (68180-875-11) > 1 KIT in 1 BLISTER PACK 3 pouch 2013-12-23 2022-03-31 No No Current 68180-875-73 68180087573 3 POUCH in 1 CARTON (68180-875-73) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK * 21 TABLET in 1 BLISTER PACK (68180-495-74) * 7 TABLET in 1 BLISTER PACK (68180-500-74) 3 pouch 2020-11-04 0000-00-00 No No Current